Hematologic issues in the geriatric surgical patient

Area of Science:

• Geriatric Medicine
• Pharmacology
• Hematology

Background:

• Geriatric patients exhibit increased susceptibility to hemorrhagic complications following surgical procedures and traumatic injuries.
• This population frequently uses anticoagulant and antiplatelet medications, elevating bleeding risks.
• Coexisting chronic diseases, autoimmune conditions, and nutritional deficits can precipitate coagulation factor and platelet dysfunction.

Purpose of the Study:

• To underscore the importance of familiarity with current anticoagulant and antiplatelet therapies.
• To review the mechanisms of action and available reversal agents for these medications.
• To guide the appropriate management of bleeding risks in geriatric patients.

Main Methods:

• Literature review of anticoagulant and antiplatelet medications.
• Analysis of drug mechanisms of action and reversal strategies.
• Examination of potential procoagulant agents for managing new oral anticoagulant-related bleeding.

Main Results:

• New oral anticoagulants currently lack specific Food and Drug Administration (FDA)-approved reversal agents.
• Established procoagulant agents, approved for other indications, may serve as effective reversal options.
• Comprehensive knowledge of medication profiles is essential for risk mitigation.

Conclusions:

• Effective management of geriatric patients requires a thorough understanding of anticoagulant and antiplatelet pharmacology.
• Proactive consideration of reversal strategies, even with agents not FDA-approved for this specific use, is vital.
• Minimizing hemorrhagic complications in elderly patients necessitates tailored pharmacological approaches.